Biocompatibility studies of naltrexone sustained release formulations
- 31 March 1992
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 19 (1-3) , 299-314
- https://doi.org/10.1016/0168-3659(92)90085-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Acute histopathological response to a new biodegradable polypeptidic polymer for implantable drug delivery systemJournal of Biomedical Materials Research, 1989
- Drug-Coupled Poly(Amino Acids) as Polymeric ProdrugsJournal of Bioactive and Compatible Polymers, 1988
- Biodegradation of and tissue reaction to poly(DL‐lactide) microcapsulesJournal of Biomedical Materials Research, 1986
- Ultrastructural observations of cells at the interface of a biodegradable polymer: Polyglactin 910Journal of Biomedical Materials Research, 1983
- Long‐term in vivo studies of poly(2‐hydroxyethyl methacrylate)Journal of Biomedical Materials Research, 1982
- Inhibition of inflammatory pain by naloxone and its N methyl quaternary analogueLife Sciences, 1982
- The role of the fibrous capsule in the function of implanted drug‐polymer sustained release systemsJournal of Biomedical Materials Research, 1981
- Biocompatibility of polymeric delivery systems for macromoleculesJournal of Biomedical Materials Research, 1981
- Antibiotic tissue levels: are tissue cages relevant for their measurement?Journal of Antimicrobial Chemotherapy, 1979
- Lactic/glycolic acid polymers as narcotic antagonist delivery systemsLife Sciences, 1975